MRPL19 Antibody, HRP conjugated
-
中文名称:MRPL19兔多克隆抗体, HRP偶联
-
货号:CSB-PA014826EB01HU
-
规格:¥880
-
其他:
产品详情
-
产品名称:Rabbit anti-Homo sapiens (Human) MRPL19 Polyclonal antibody
-
Uniprot No.:
-
基因名:MRPL19
-
别名:MRPL19 antibody; KIAA0104 antibody; MRPL15 antibody; 39S ribosomal protein L19 antibody; mitochondrial antibody; L19mt antibody; MRP-L19 antibody; 39S ribosomal protein L15 antibody; mitochondrial antibody; L15mt antibody; MRP-L15 antibody; Mitochondrial large ribosomal subunit protein bL19m antibody
-
宿主:Rabbit
-
反应种属:Human
-
免疫原:Recombinant Human 39S ribosomal protein L19, mitochondrial protein (1-292AA)
-
免疫原种属:Homo sapiens (Human)
-
标记方式:HRP
-
克隆类型:Polyclonal
-
抗体亚型:IgG
-
纯化方式:>95%, Protein G purified
-
浓度:It differs from different batches. Please contact us to confirm it.
-
保存缓冲液:Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 -
产品提供形式:Liquid
-
应用范围:ELISA
-
Protocols:
-
储存条件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
货期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途:For Research Use Only. Not for use in diagnostic or therapeutic procedures.
相关产品
靶点详情
-
基因功能参考文献:
- MRPL19 was initially implicated in dyslexia through family-based studies. PMID: 25448322
- study failed to show any association of MRPL19 SNPs with developmental dyslexia in an Indian population. PMID: 23954868
- Study refined the 2p12 candidate region in two populations and report evidence supporting MRPL19 and C2ORF3 as candidate susceptibility genes for dyslexia. PMID: 17309879
-
亚细胞定位:Mitochondrion.
-
蛋白家族:Bacterial ribosomal protein bL19 family
-
数据库链接:
Most popular with customers
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
-